Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome subunit alpha 6 pseudogene 4 (PSMA6P4) is a processed pseudogene on the human genome that shares sequence similarity with the functional proteasome subunit alpha type-6 (PSMA6) gene[2][5]. Pseudogenes arise from duplication or retrotransposition events and typically accumulate mutations that prevent translation into functional protein, thus lacking the molecular activities of their canonical gene counterparts[8]. PSMA6P4 is annotated but does not have an established biological or clinical role—it is not an active participant in proteasome function nor a target for drugs or diagnostics. If you intended the *functional* protein-coding gene, you should refer to **Proteasome subunit alpha type-6 (PSMA6)**, which is a structural component of the proteasome complex involved in protein degradation, cellular regulation, and is considered a therapeutic target in some disease contexts[1][4][7].
None applicable; as a pseudogene, there is no mechanism of drug action involved.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome subunit alpha 6 pseudogene 4 (PSMA6P4).